A Phase I Trial of CCT303-406 in Patients With Relapsed or Refractory HER2 Positive Solid Tumors

Conditions:   Solid Tumor;   Gastric Cancer;   Breast Cancer;   Ovarian Cancer;   Sarcoma Intervention:   Biological: CCT303-406 Sponsors:   Shanghai PerHum Therapeutics Co., Ltd.;   Shanghai Zhongshan Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials